Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-14 Option Award | 2023-12-18 4:30 pm | N/A 2033-12-13 | Mural Oncology plc | MURA | Jackson Scott Thomas Director | 15,021 | $0 | 15,021 (Direct) | View |
| 2023-10-05 Option Award | 2023-10-10 5:19 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Jackson Scott Thomas Director | 20,000 | $0 | 35,000 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 4:57 pm | N/A 2033-05-31 | MACROGENICS INC | MGNX | Jackson Scott Thomas Director | 23,500 | $0 | 23,500 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-22 4:18 pm | N/A 2033-05-18 | GLYCOMIMETICS INC | GLYC | Jackson Scott Thomas Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-09-15 Option Award | 2022-09-19 5:45 pm | N/A N/A | Spero Therapeutics Inc. | SPRO | Jackson Scott Thomas Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-23 9:07 pm | N/A 2032-05-19 | MACROGENICS INC | MGNX | Jackson Scott Thomas Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-05-18 Option Award | 2022-05-20 4:10 pm | N/A 2032-05-17 | GLYCOMIMETICS INC | GLYC | Jackson Scott Thomas Director | 21,000 | $0 | 21,000 (Direct) | View |
| 2021-08-17 Option Award | 2021-08-18 4:48 pm | N/A 2031-08-17 | Spero Therapeutics Inc. | SPRO | Jackson Scott Thomas Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2021-05-18 Option Award | 2021-05-27 8:55 pm | N/A 2031-05-17 | GLYCOMIMETICS INC | GLYC | Jackson Scott Thomas Director | 15,750 | $0 | 15,750 (Direct) | View |
| 2021-05-13 Option Award | 2021-05-17 9:28 pm | N/A 2031-05-13 | MACROGENICS INC | MGNX | Jackson Scott Thomas Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-10-27 Option Award | 2020-10-27 5:34 pm | N/A 2030-10-27 | Spero Therapeutics Inc. | SPRO | Jackson Scott Thomas Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2020-06-23 Option Award | 2020-06-23 5:33 pm | N/A 2030-06-23 | Spero Therapeutics Inc. | SPRO | Jackson Scott Thomas Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-05-22 Option Award | 2020-05-27 4:29 pm | N/A 2030-05-21 | GLYCOMIMETICS INC | GLYC | Jackson Scott Thomas Director | 21,000 | $0 | 21,000 (Direct) | View |
| 2020-05-14 Option Award | 2020-05-15 4:37 pm | N/A 2030-05-14 | MACROGENICS INC | MGNX | Jackson Scott Thomas Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2019-05-17 Option Award | 2019-05-21 4:04 pm | N/A 2029-05-16 | GLYCOMIMETICS INC | GLYC | Jackson Scott Thomas Director | 21,000 | $0 | 21,000 (Direct) | View |
| 2019-05-16 Option Award | 2019-05-20 5:47 pm | N/A 2029-05-16 | MACROGENICS INC | MGNX | Jackson Scott Thomas Director | 10,000 | $0 | 10,000 (Direct) | View |